1.
Is GLP-1 receptor agonist therapy safe for patients with intraductal papillary mucinous neoplasm?. Swiss Med Wkly [Internet]. 2025 Oct. 15 [cited 2025 Oct. 26];155(10):4850. Available from: https://www.smw.ch/index.php/smw/article/view/4850